<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">rmt</journal-id><journal-title-group><journal-title xml:lang="ru">Общая реаниматология</journal-title><trans-title-group xml:lang="en"><trans-title>General Reanimatology</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1813-9779</issn><issn pub-type="epub">2411-7110</issn><publisher><publisher-name>FSBI "SRIGR" RAMS</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.15360/1813-9779-2012-1-36</article-id><article-id custom-type="elpub" pub-id-type="custom">rmt-243</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ПРАКТИКУЮЩЕМУ ВРАЧУ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>FOR PRACTIONER</subject></subj-group></article-categories><title-group><article-title>Гемофильтрация и гемодиализ в профилактике и лечении острой почечной недостаточности после операций на сердце с искусственным кровообращением</article-title><trans-title-group xml:lang="en"><trans-title>Hemofiltration and Hemodialysis in the Prevention and Treatment of Acute Renal Failure after Cardiac Surgery under Extracorporeal Circulation</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Табакьян</surname><given-names>Е. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Tabakyan</surname><given-names>E. A.</given-names></name></name-alternatives><email xlink:type="simple">tabakyan@mail.ru</email></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Партигулов</surname><given-names>С. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Partigulov</surname><given-names>S. A.</given-names></name></name-alternatives></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Савушкина</surname><given-names>Т. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Savushkina</surname><given-names>T. N.</given-names></name></name-alternatives></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Лепилин</surname><given-names>М. Г.</given-names></name><name name-style="western" xml:lang="en"><surname>Lepilin</surname><given-names>M. G.</given-names></name></name-alternatives></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Акчурин</surname><given-names>Р. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Akchurin</surname><given-names>R. S.</given-names></name></name-alternatives></contrib></contrib-group><pub-date pub-type="collection"><year>2012</year></pub-date><pub-date pub-type="epub"><day>20</day><month>02</month><year>2012</year></pub-date><volume>8</volume><issue>1</issue><issue-title>Том VIII № 1 2012 г.</issue-title><fpage>36</fpage><lpage>36</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Табакьян Е.А., Партигулов С.А., Савушкина Т.Н., Лепилин М.Г., Акчурин Р.С., 2012</copyright-statement><copyright-year>2012</copyright-year><copyright-holder xml:lang="ru">Табакьян Е.А., Партигулов С.А., Савушкина Т.Н., Лепилин М.Г., Акчурин Р.С.</copyright-holder><copyright-holder xml:lang="en">Tabakyan E.A., Partigulov S.A., Savushkina T.N., Lepilin M.G., Akchurin R.S.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.reanimatology.com/rmt/article/view/243">https://www.reanimatology.com/rmt/article/view/243</self-uri><abstract><p>Цель исследования — анализ эффективности гемофильтрации (ГФ) на этапе искусственного кровообращения (ИК) при операциях на сердце, для профилактики острого снижения функции почек и развития острой почечной недостаточности (ОПН). Материал и методы. Риск развития после операции ОПН, требующей применения заместительной почечной терапии (ЗПТ), оценивали до операции согласно сумме баллов и процентов риска по Cleveland score (2005). ГФ на этапе ИК применяли у больных высокого риска развития ОПН. Процедуру проводили посредством совмещения 2-х экстракорпоральных контуров: ИК и аппарата Diapact®CRRT. В случае развития ОПН, 3 стадия по Risk, Injury, Failure, Loss of kidney function, End-stage Renal Disease (RIFLE) 2004 и Acute Kidney Injury Network (AKIN) 2007, после операции с ИК проводили продолжительную вено-венозную гемофильтрацию (ПВВГФ) и продолжительный высокопоточный гемодиализ (ПВГД) в режиме рециркуляции диализата. Для оценки достоверности межгрупповых различий применяли непараметрический метод анализа по Манна—Уитни. Результаты представлены: медиана (нижний квартиль; верхний квартиль), различия считались достоверными приp&lt;0,05. Результаты. ГФ на этапе ИК. Шесть больных, возраст 65,5 (57; 70) лет, с хронической болезнью почек (ХБП), скорость клубочковой фильтрации (СКФ) по Кокрофту-Гаулту до операции 50 (41,5; 65) мл/мин/1,73 м2. Максимальное снижение СКФ после ИК на 2,9 (0,7; 7) мл/мин/1,73 м2. Контрольная группа — 12 больных, возраст 73 (63; 75) лет. Наблюдали снижение СКФ после операции на 17 (13,7; 22) мл/мин/1,73 м2. У одного пациента контрольной группы развилась ОПН и полиорганная недостаточность (ПОН), потребовалось проведение ПВВГФ и ПВГД. Заключение. Использование интраоперационной гемофильтрации у больных с высоким риском снижения функции почек, вероятно, позволит предотвратить значительное снижение СКФ и развитие ОПН после операций с ИК. Ключевые слова: операции на сердце с искусственным кровообращением, острая почечная недостаточность, гемофильтрация, гемодиализ.</p></abstract><trans-abstract xml:lang="en"><p>Objective: to analyze the efficiency of hemofiltration (HF) in the stage of extracorporeal circulation (EC) during cardiac surgery in order to prevent acute renal function lowering and the development of acute renal failure (ARF). Materials and methods. The risk of postoperative ARF requiring renal replacement therapy (RRT) was preoperatively assessed by the summed Cleveland risk score and percentage (2005). HF during EC was used in patients at high risk for ARF. The procedure was performed, by combining 2 extracorporeal circuits: EC and a Diapact®CRRT apparatus. With evolving ARF, Stage 3 after Risk, Injury, Failure, Loss of Kidney Function, End-stage Renal Disease (RIFLE), 2004, and Acute Kidney Injury Network (AKIN), 2007, continuous venovenous hemofiltration (CVVHF) and continuous high-flow hemodialysis (CHFHD) were done in the dialysate recirculation mode after surgery under EC. The Mann-Whitney non-parametric test was used to estimate the significance of intergroup differences. The results are presented: median (lower quartile; upper quartile), the differences considered to be significant atpResults. HF during EC; 6 patients were aged 65.5 (range 57—70) years with chronic kidney disease, preoperative glomerular filtration rate (GFR) was 50 (range 41.5—65) ml/min/1.73 m2 using the Cockroft-Gault formula. The maximum GFR decrease by 2.9 (range 0.7—7) ml/min/1.73 m2 was seen after EC. A control group comprised 12 patients aged 73 (range 63—75) years. There was a postoperative GFR reduction by 17 (range 13.7—22) ml/min/1.73 m2. One patient from the control group developed ARF and multiple organ dysfunction, which required CVVHF and CHFHD. Conclusion. The use of intraoperative HF in patients at high risk for renal function lowering is likely to prevent a considerable GFR reduction and ARF after surgery under EC.</p></trans-abstract><kwd-group xml:lang="en"><kwd>cardiac surgery under extracorporeal circulation</kwd><kwd>acute renal failure</kwd><kwd>hemofiltration</kwd><kwd>hemodialysis.</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Rosnerand M. H., Okusa M. D.</mixed-citation><mixed-citation xml:lang="en">Rosnerand M. H., Okusa M. D.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Kilo J, Margreiter J. E., Ruttmann E. et al.Slightly elevated serum creatinine predicts renal failure requiring hemofiltration after cardiac surgery. Heart Surg. Forum 2005; 8 (1): E34—E38.</mixed-citation><mixed-citation xml:lang="en">Kilo J, Margreiter J. E., Ruttmann E. et al.Slightly elevated serum creatinine predicts renal failure requiring hemofiltration after cardiac surgery. Heart Surg. Forum 2005; 8 (1): E34—E38.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Elahi M. M, Lim M. Y., Joseph R. N. et al.Early hemofiltration improves survival in post-cardiotomy patients with acute renal failure. Eur. J. Cardiothorac. Surg. 2004; 26 (5): 1027—1031.</mixed-citation><mixed-citation xml:lang="en">Elahi M. M, Lim M. Y., Joseph R. N. et al.Early hemofiltration improves survival in post-cardiotomy patients with acute renal failure. Eur. J. Cardiothorac. Surg. 2004; 26 (5): 1027—1031.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Perez-Valdivieso J. R., Monedero P., Vives M. et al.Cardiac-surgery associated acute kidney injury requiring renal replacement therapy. A Spanish retrospective case-cohort study. BMC Nephrol. 2009; 10: 27.</mixed-citation><mixed-citation xml:lang="en">Perez-Valdivieso J. R., Monedero P., Vives M. et al.Cardiac-surgery associated acute kidney injury requiring renal replacement therapy. A Spanish retrospective case-cohort study. BMC Nephrol. 2009; 10: 27.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">ХенслиФ. А. -мл., МартинД. Е., ГревлиГ. П.Практическая кардио-анестезиология. 3-е изд. М.: Медицинское информационное агентство; 2008. 822—857.</mixed-citation><mixed-citation xml:lang="en">ХенслиФ. А. -мл., МартинД. Е., ГревлиГ. П.Практическая кардио-анестезиология. 3-е изд. М.: Медицинское информационное агентство; 2008. 822—857.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Candela-Toha A., Elias-Martin E., Abraira V. et al.Predicting acute renal failure after cardiac surgery: external validation of two new clinical scores. Clin. J. Am. Soc. Nephrol. 2008; 3 (5): 1260—1265.</mixed-citation><mixed-citation xml:lang="en">Candela-Toha A., Elias-Martin E., Abraira V. et al.Predicting acute renal failure after cardiac surgery: external validation of two new clinical scores. Clin. J. Am. Soc. Nephrol. 2008; 3 (5): 1260—1265.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Roscitano A., Benedetto U., Goracci M. et al.Intraoperative continuous venovenous hemofiltration during coronary surgery. Asian Cardiovasc. Thorac. Ann. 2009; 17 (5): 462—466.</mixed-citation><mixed-citation xml:lang="en">Roscitano A., Benedetto U., Goracci M. et al.Intraoperative continuous venovenous hemofiltration during coronary surgery. Asian Cardiovasc. Thorac. Ann. 2009; 17 (5): 462—466.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Ricci Z, Romagnoli S., Ronco C.Renal support. Minerva Anestesiol. 2011; 77 (12): 1204—1215.</mixed-citation><mixed-citation xml:lang="en">Ricci Z, Romagnoli S., Ronco C.Renal support. Minerva Anestesiol. 2011; 77 (12): 1204—1215.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Prowle J. R., Bellomo R.Continuous renal replacement therapy: recent advances and future research. Nat. Rev. Nephrol. 2010; 6 (9): 521—52</mixed-citation><mixed-citation xml:lang="en">Prowle J. R., Bellomo R.Continuous renal replacement therapy: recent advances and future research. Nat. Rev. Nephrol. 2010; 6 (9): 521—52</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Bapat V., Sabetai M, Roxburgh J. et al.Early and intensive continuous veno-venous hemofiltration for acute renal failure after cardiac surgery. Interact. Cardiovasc. Thorac. Surg. 2004; 3 (3): 426—430.</mixed-citation><mixed-citation xml:lang="en">Bapat V., Sabetai M, Roxburgh J. et al.Early and intensive continuous veno-venous hemofiltration for acute renal failure after cardiac surgery. Interact. Cardiovasc. Thorac. Surg. 2004; 3 (3): 426—430.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Lanquetot H., Leprince T., Ragot S. et al.Antithrombin level and circuit thrombosis during hemofiltration after cardiopulmonary bypass. Intensive Care Med. 2008; 34 (11): 2068—2075.</mixed-citation><mixed-citation xml:lang="en">Lanquetot H., Leprince T., Ragot S. et al.Antithrombin level and circuit thrombosis during hemofiltration after cardiopulmonary bypass. Intensive Care Med. 2008; 34 (11): 2068—2075.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">БарбарашЛ. С., ПлотниковГ. П., ШукевичД. Л. исоавт.0боснова-ние ранней заместительной почечной терапии при полиорганной недостаточности. 0бщая реаниматология 2010; VI (6): 29—33.</mixed-citation><mixed-citation xml:lang="en">БарбарашЛ. С., ПлотниковГ. П., ШукевичД. Л. исоавт.0боснова-ние ранней заместительной почечной терапии при полиорганной недостаточности. 0бщая реаниматология 2010; VI (6): 29—33.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Ямпольский М. А., Заболотских И. Б., Ямпольский А. Ф.Элиминация низкомолекулярных белков у больных с изолированной острой почечной недостаточностью. 0бщая реаниматология 2010; VI (5): 40—45.</mixed-citation><mixed-citation xml:lang="en">Ямпольский М. А., Заболотских И. Б., Ямпольский А. Ф.Элиминация низкомолекулярных белков у больных с изолированной острой почечной недостаточностью. 0бщая реаниматология 2010; VI (5): 40—45.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Karkouti K., Wijeysundera D. N., Yau T. M. et al.Acute kidney injury</mixed-citation><mixed-citation xml:lang="en">Karkouti K., Wijeysundera D. N., Yau T. M. et al.Acute kidney injury</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">after cardiac surgery: focus on modifiable risk factors. Circulation 2009; 119 (4): 495—502.</mixed-citation><mixed-citation xml:lang="en">after cardiac surgery: focus on modifiable risk factors. Circulation 2009; 119 (4): 495—502.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Englberger L., Suri R. M., Li Z. et al.Clinical accuracy of RIFLE and Acute Kidney Injury Network (AKIN) criteria for acute kidney injury in patients under going cardiac surgery. Crit. Care 2011; 15 (1): R16.</mixed-citation><mixed-citation xml:lang="en">Englberger L., Suri R. M., Li Z. et al.Clinical accuracy of RIFLE and Acute Kidney Injury Network (AKIN) criteria for acute kidney injury in patients under going cardiac surgery. Crit. Care 2011; 15 (1): R16.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Shara N. M., Resnick H. E., Lu L. et al.Decreased GFR estimated by MDRD or Cockcroft-Gault equation predicts incident CVD: the strong heart study. J. Nephrol. 2009; 22 (3): 373—380.</mixed-citation><mixed-citation xml:lang="en">Shara N. M., Resnick H. E., Lu L. et al.Decreased GFR estimated by MDRD or Cockcroft-Gault equation predicts incident CVD: the strong heart study. J. Nephrol. 2009; 22 (3): 373—380.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Thakar C. V., Arrigain S., Worley S. et al.A clinical score to predict acute renal failure after cardiac surgery. J. Am. Soc. Nephrol. 2005; 16 (1): 162—168.</mixed-citation><mixed-citation xml:lang="en">Thakar C. V., Arrigain S., Worley S. et al.A clinical score to predict acute renal failure after cardiac surgery. J. Am. Soc. Nephrol. 2005; 16 (1): 162—168.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Dirkes S., Hodge K.Continuous renal replacement therapy in the adult intensive care unit: history and current trends. Crit. Care Nurse 2007; 27 (2): 61—80.</mixed-citation><mixed-citation xml:lang="en">Dirkes S., Hodge K.Continuous renal replacement therapy in the adult intensive care unit: history and current trends. Crit. Care Nurse 2007; 27 (2): 61—80.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Cole L., Bellomo R., Davenport P. et al.Cytokine removal during continuous renal replacement therapy: an ex vivo comparison of convection and diffusion. Int. J. Artif. 0rgans 2004; 27 (5): 388—397.</mixed-citation><mixed-citation xml:lang="en">Cole L., Bellomo R., Davenport P. et al.Cytokine removal during continuous renal replacement therapy: an ex vivo comparison of convection and diffusion. Int. J. Artif. 0rgans 2004; 27 (5): 388—397.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am. J. Kidney Dis. 2002; 39 (2 Suppl 1): S1—S266.</mixed-citation><mixed-citation xml:lang="en">National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am. J. Kidney Dis. 2002; 39 (2 Suppl 1): S1—S266.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Hirose H, Amano A., Takahashi A., Nagano N.Coronary artery bypass grafting for patients with non-dialysis-dependent renal dysfunction (serum creatinine &gt; or = 2. 0mg/dl). Eur. J. Cardiothorac. Surg. 2001; 20 (3): 565—572.</mixed-citation><mixed-citation xml:lang="en">Hirose H, Amano A., Takahashi A., Nagano N.Coronary artery bypass grafting for patients with non-dialysis-dependent renal dysfunction (serum creatinine &gt; or = 2. 0mg/dl). Eur. J. Cardiothorac. Surg. 2001; 20 (3): 565—572.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">van de Wal R. M, van Brussel B. L., Voors A. A. et al.Mild preopera-tive renal dysfunction as a predictor of long-term clinical outcome after coronary bypass surgery. J. Thorac. Cardiovasc. Surg. 2005; 129 (2): 330—335.</mixed-citation><mixed-citation xml:lang="en">van de Wal R. M, van Brussel B. L., Voors A. A. et al.Mild preopera-tive renal dysfunction as a predictor of long-term clinical outcome after coronary bypass surgery. J. Thorac. Cardiovasc. Surg. 2005; 129 (2): 330—335.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Ranucci M., De Toffol B., Isgro G. et al.Hyperlactatemia during cardiopulmonary bypass: determinants and impact on postoperative outcome. Crit. Care 2006; 10 (6): R167.</mixed-citation><mixed-citation xml:lang="en">Ranucci M., De Toffol B., Isgro G. et al.Hyperlactatemia during cardiopulmonary bypass: determinants and impact on postoperative outcome. Crit. Care 2006; 10 (6): R167.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Lassing A., Donner E., Grubhoter G. et al.Lack of renoprotective effects of dopamine and furosemide during cardiac surgery. J. Am. Soc. Nephrol. 2000; 11 (1): 97—104.</mixed-citation><mixed-citation xml:lang="en">Lassing A., Donner E., Grubhoter G. et al.Lack of renoprotective effects of dopamine and furosemide during cardiac surgery. J. Am. Soc. Nephrol. 2000; 11 (1): 97—104.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Karajala V., Mansour W., Kellum J. A.Diuretics in acute kidney injury. Minerva Anestesiol. 2009; 75 (5): 251—257.</mixed-citation><mixed-citation xml:lang="en">Karajala V., Mansour W., Kellum J. A.Diuretics in acute kidney injury. Minerva Anestesiol. 2009; 75 (5): 251—257.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Bennett M., Dent C. L., Ma Q. et al.Urine NGAL predicts severity of acute kidney injury after cardiac surgery: a prospective study. Clin. J. Am. Soc. Nephrol. 2008; 3 (3): 665—673.</mixed-citation><mixed-citation xml:lang="en">Bennett M., Dent C. L., Ma Q. et al.Urine NGAL predicts severity of acute kidney injury after cardiac surgery: a prospective study. Clin. J. Am. Soc. Nephrol. 2008; 3 (3): 665—673.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
